Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Hypomyelinating Leukodystrophy due to HSPD1 Mutations: A New Patient

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. SLC7A3: In Silico Prediction of a Potential New Cause of Childhood Epilepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Variant of Rett Syndrome and CDKL5 Gene: Clinical and Autonomic Description of 10 Cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Renal Phenotype in Mitochondrial Diseases: A Multicenter Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Biallelic Loss-of-Function NDUFA12 Variants Cause a Wide Phenotypic Spectrum from Leigh/Leigh-Like Syndrome to Isolated Optic Atrophy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The hypomyelinating leukodystrophies (HMLs) encompass the X-linked Pelizaeus-Merzbacher disease (PMD) caused by PLP1 mutations and known as the classical form of HML as well as Pelizaeus-Merzbacher-like disease (PMLD) (Online Mendelian Inheritance in Man [OMIM] 608804 and OMIM 260600) due to GJC2 mutations. In addition, mutations in at least 10 other genes are known to cause HMLs. In 2008, an Israeli family with clinical and neuroimaging findings similar to those found in PMD was reported. The patients were found to have a homozygous missense mutation in HSPD1, encoding the mitochondrial heat-shock protein 60 (Hsp60), and the disorder was defined as the autosomal recessive mitochondrial Hsp60 chaperonopathy (MitCHAP-60) disease. We here report the first case of this severe neurodegenerative disease since it was first described. Given the fact that the families carried the same mutation our patient probably belongs to the same extended family as the Israeli family. In conclusion, the MitCHAP-60 disease should be considered as a rare differential diagnosis in HML.

Original languageEnglish
JournalNeuropediatrics
Volume47
Issue number5
Pages (from-to)332-5
ISSN0174-304X
DOIs
Publication statusPublished - 12 Jul 2016

ID: 48257742